Cystatin C as a biomarker of chronic kidney disease: latest developments
Introduction Chronic kidney disease (CKD) is common, occurring in over 10% of individuals globally, and is increasing in prevalence. The limitations of traditional biomarkers of renal dysfunction, such as serum creatinine, have been well demonstrated in the literature. Therefore, augmenting clinical...
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Revisão |
| Idioma: | anglès |
| Publicat: |
2020
|
| Accés en línia: | https://doi.org/10.1080/14737159.2020.1768849 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
Sigues el primer a deixar un comentari!